Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | LAP3 | P28838 | 4/20 | 0.35 |
| ▸ | FDPS | P14324 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 3/20 | 0.31 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16616020 | 0.67 | FDPS (0.40) | LAP3FDPSKDM4EMMP2THRB | |
| SCHEMBL5165733 | 0.62 | — | — | |
| SCHEMBL240710 | 0.62 | — | — | |
| Phosphoric Acid SCHEMBL28601437 | 0.62 | CA2 (0.46) | CA2FDPSKDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL28557574 | 0.62 | CA2 (0.46) | CA2FDPSKDM4EMMP2THRB | |
| SCHEMBL11095218 | 0.60 | — | — | |
| SCHEMBL7159072 | 0.60 | CA2 (0.43) | CA2FDPS | |
| SCHEMBL190532 | 0.60 | — | — | |
| SCHEMBL17626543 | 0.60 | LAP3 (0.47) | CA2LAP3FDPSKDM4EMMP2 | |
| SCHEMBL16168099 | 0.60 | LAP3 (0.47) | CA2LAP3FDPSKDM4EMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0742263-B1 | Silyl phosphonate as stabilizing agent for polydiorganosiloxanes | DOW CORNING (US) | 1999-06-02 | — | — | EP | claimed |
| US-20150099193-A1 | ELECTROLYTIC SOLUTION FOR NON-AQUEOUS ENERGY STORAGE DEVICE AND LITHIUM ION SECONDARY BATTERY | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2015-04-09 | — | — | US | disclosed |
| EP-2180002-A1 | Method for producing onium salts with dialkyl phosphonate anions with low halogenide content | Merck Patent GmbH (DE) | 2010-04-28 | — | — | EP | disclosed |
| US-20090253914-A1 | PROCESS FOR THE PREPARATION OF ONIUM SALTS WITH DIALKYLPHOSPHATE, DIALKYLPHOSPHINATE OR (O-ALKYL)ALKYL- OR ALKYLPHOSPHONATE ANIONS HAVING A LOW HALIDE CONTENT | MERCK PATENT GMBH (DE) | 2009-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253914-A1 | PROCESS FOR THE PREPARATION OF ONIUM SALTS WITH DIALKYLPHOSPHATE, DIALKYLPHOSPHINATE OR (O-ALKYL)ALKYL- OR ALKYLPHOSPHONATE ANIONS HAVING A LOW HALIDE CONTENT | INPPL1, PHYKPL, AGPS | CA2 1214/4885LAP3 1732/4885FDPS 303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.